Cargando...

非小细胞肺癌免疫治疗进展

Globally, Lung cancer is the leading cause of cancer-related death of high morbidity and mortality with poor prognosis, which needs some more effective and less toxic therapies. The immunotherapies offer a novel approach for the treatment of patients with non-small cell lung cancer (NSCLC) in both t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Zhongguo Fei Ai Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado: 中国肺癌杂志编辑部 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019365/
https://ncbi.nlm.nih.gov/pubmed/24667269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.03.17
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!